Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 5

Treatment of Crohn’s disease with colony-stimulating factors: An overview

Authors Luisa Guidi, Giammarco Mocci, Manuela Marzo, Sergio Rutella

Published 10 October 2008 Volume 2008:4(5) Pages 927—934

DOI https://doi.org/10.2147/TCRM.S2756

Luisa Guidi1, Giammarco Mocci1, Manuela Marzo1, Sergio Rutella2

1Department of Internal Medicine, Operative Unit of Gastroenterology, and 2Department of Hematology, Laboratory of Immunology, Università Cattolica del Sacro Cuore, Rome, Italy

Abstract: Current treatments for Crohn’s disease are aimed at suppressing excessive immune activation in the bowel walls. However, alternative strategies can be drawn. These involve the augmentation of the innate immune response, in the hypothesis that patients affected with Crohn’s disease are characterized by a relative immunodeficiency, with failure of the defensive barrier to luminal microbes and microbial products, resulting in a chronic inflammatory process sustained by T-cells. Alternatively, therapy could act by enhancing the number or the activity of subpopulations of T regulatory cells, able to reduce T-cell activation. Colony-stimulating factors are substances that could be efficacious in these settings. In fact, besides in vitro and animal studies, some human studies have been conducted in recent years with both granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor, the results of which are reported here.

Keywords: inflammatory bowel disease, Crohn’s disease treatment, G-CSF, GM-CSF

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Readers of this article also read:

Stress and burnout in residents: impact of mindfulness-based resilience training

Goldhagen BE, Kingsolver K, Stinnett SS, Rosdahl JA

Advances in Medical Education and Practice 2015, 6:525-532

Published Date: 25 August 2015

Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules

Clavreul A, Montagu A, Lainé AL, Tétaud C, Lautram N, Franconi F, Passirani C, Vessières A, Montero-Menei CN, Menei P

International Journal of Nanomedicine 2015, 10:1259-1271

Published Date: 12 February 2015

Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin

Zhang Y, Jiang X, Peng K, Chen C, Fu L, Wang Z, Feng J, Liu Z, Zhang H, Liang G, Pan Z

Drug Design, Development and Therapy 2014, 8:2161-2171

Published Date: 4 November 2014

Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review

Brennan JL, Leung JG, Gagliardi JP, Rivelli SK, Muzyk AJ

Clinical Pharmacology: Advances and Applications 2013, 5:99-107

Published Date: 3 July 2013

Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups

Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han DW

International Journal of Nanomedicine 2011, 6:3219-3231

Published Date: 7 December 2011

Anterior segment dysgenesis in a child with factor VII deficiency

Francis Beby, Sandrine Meunier, Pierre Cochat, Olivier Roche, Florent Aptel, et al

Clinical Ophthalmology 2007, 1:335-337

Published Date: 15 December 2007

Endovascular stent-graft placement for vascular failure of the thoracic aorta

Yoshihiko Kurimoto, Kiyofumi Morishita, Yasufumi Asai

Vascular Health and Risk Management 2006, 2:109-116

Published Date: 15 June 2006

Vascular risks and management of obesity in children and adolescents

Courtney J Jolliffe, Ian Janssen

Vascular Health and Risk Management 2006, 2:171-187

Published Date: 15 June 2006